发明名称 EMBIGIN INHIBITION FOR PROMOTION OF HEMATOPOIETIC STEM AND PROGENITOR CELL EXPANSION
摘要 Disclosed herein are methods for enhancing hematopoietic reconstitution of a subject. One method involves administering a therapeutically effective amount of an inhibitor of Embigin to a recipient subject and can also optionally include administering hematopoietic stem/progenitor cells to the subject. Another method involves administering an inhibitor of Embigin to a donor prior to harvest of hematopoietic stem/progenitor cells. Pharmaceutical compositions relating to the methods are also described.
申请公布号 WO2017004127(A1) 申请公布日期 2017.01.05
申请号 WO2016US39969 申请日期 2016.06.29
申请人 THE GENERAL HOSPITAL CORPORATION;PRESIDENT AND FELLOWS OF HARVARD COLLEGE 发明人 SCADDEN, David T.;SILBERSTEIN, Lev;KHARCHENKO, Peter
分类号 A61K35/14;A61K35/28;A61K35/44;A61K35/50;A61K38/17;A61K39/00;A61K39/395;A61P7/00 主分类号 A61K35/14
代理机构 代理人
主权项
地址